465 related articles for article (PubMed ID: 31011258)
1. Clinical characteristics of non-alcoholic fatty liver disease in Chinese adult hypopituitary patients.
Yuan XX; Zhu HJ; Pan H; Chen S; Liu ZY; Li Y; Wang LJ; Lu L; Yang HB; Gong FY
World J Gastroenterol; 2019 Apr; 25(14):1741-1752. PubMed ID: 31011258
[TBL] [Abstract][Full Text] [Related]
2. Metabolic parameters and nonalcoholic fatty liver disease in hypopituitary men.
Hong JW; Kim JY; Kim YE; Lee EJ
Horm Metab Res; 2011 Jan; 43(1):48-54. PubMed ID: 20865648
[TBL] [Abstract][Full Text] [Related]
3. Relationship between growth hormone deficiency and nonalcoholic fatty liver disease in patients with pituitary stalk interruption syndrome.
Huang Q; Xu H; Wang X; Mao J; Yu B; Zhu Y; Zhang R; Sun B; Zhang J; Ji W; Ma W; Nie M; Wu X
Clin Endocrinol (Oxf); 2022 Nov; 97(5):612-621. PubMed ID: 35384023
[TBL] [Abstract][Full Text] [Related]
4. Association between the non-HDL-cholesterol to HDL-cholesterol ratio and non-alcoholic fatty liver disease in Chinese children and adolescents: a large single-center cross-sectional study.
Yang S; Zhong J; Ye M; Miao L; Lu G; Xu C; Xue Z; Zhou X
Lipids Health Dis; 2020 Nov; 19(1):242. PubMed ID: 33222696
[TBL] [Abstract][Full Text] [Related]
5. Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.
Yi M; Chen RP; Yang R; Chen H
Diabet Med; 2017 Apr; 34(4):505-513. PubMed ID: 27334577
[TBL] [Abstract][Full Text] [Related]
6. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
7. Associations among FT
Xiao J; Zhu C; Zhang X; Sun L; Gao C; Liang X; He Q; Liu M
Endocr J; 2022 Jun; 69(6):659-667. PubMed ID: 35034938
[TBL] [Abstract][Full Text] [Related]
8. Rapidly progressive non-alcoholic fatty liver disease due to hypopituitarism. Report of 5 cases.
Yang Y; Qi ZR; Zhang TT; Kang YJ; Wang X
Neuro Endocrinol Lett; 2018 May; 39(2):99-104. PubMed ID: 30183204
[TBL] [Abstract][Full Text] [Related]
9. High Prevalence of Nonalcoholic Fatty Liver Disease Among Adolescents and Young Adults With Hypopituitarism due to Growth Hormone Deficiency.
Kang SJ; Kwon A; Jung MK; Chae HW; Kim S; Koh H; Shin HJ; Kim HS
Endocr Pract; 2021 Nov; 27(11):1149-1155. PubMed ID: 34126247
[TBL] [Abstract][Full Text] [Related]
10. Clinical Study of Serum Homocysteine and Non-Alcoholic Fatty Liver Disease in Euglycemic Patients.
Hu Y; Liu J; Dong X; Xu Y; Leng S; Wang G
Med Sci Monit; 2016 Nov; 22():4146-4151. PubMed ID: 27803497
[TBL] [Abstract][Full Text] [Related]
11. Low vitamin D levels and non-alcoholic fatty liver disease, evidence for their independent association in men in East China: a cross-sectional study (Survey on Prevalence in East China for Metabolic Diseases and Risk Factors (SPECT-China)).
Zhai HL; Wang NJ; Han B; Li Q; Chen Y; Zhu CF; Chen YC; Xia FZ; Cang Z; Zhu CX; Lu M; Lu YL
Br J Nutr; 2016 Apr; 115(8):1352-9. PubMed ID: 26888280
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study.
Lu ZY; Shao Z; Li YL; Wulasihan M; Chen XH
World J Gastroenterol; 2016 Apr; 22(13):3663-9. PubMed ID: 27053858
[TBL] [Abstract][Full Text] [Related]
13. Most overweight and obese Indian children have nonalcoholic fatty liver disease.
Pawar SV; Zanwar VG; Choksey AS; Mohite AR; Jain SS; Surude RG; Contractor QQ; Rathi PM; Verma RU; Varthakavi PK
Ann Hepatol; 2016 Nov-Dec 2016; 15(6):853-861. PubMed ID: 27740518
[TBL] [Abstract][Full Text] [Related]
14. Non-alcoholic fatty liver disease patients attending two metropolitan hospitals in Melbourne, Australia: high risk status and low prevalence.
George ES; Roberts SK; Nicoll AJ; Reddy A; Paris T; Itsiopoulos C; Tierney AC
Intern Med J; 2018 Nov; 48(11):1369-1376. PubMed ID: 29845719
[TBL] [Abstract][Full Text] [Related]
15. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.
Yang KC; Hung HF; Lu CW; Chang HH; Lee LT; Huang KC
Sci Rep; 2016 Jun; 6():27034. PubMed ID: 27246655
[TBL] [Abstract][Full Text] [Related]
16. Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in Germany.
Labenz C; Huber Y; Kalliga E; Nagel M; Ruckes C; Straub BK; Galle PR; Wörns MA; Anstee QM; Schuppan D; Schattenberg JM
Aliment Pharmacol Ther; 2018 Nov; 48(10):1109-1116. PubMed ID: 30288767
[TBL] [Abstract][Full Text] [Related]
17. The Relationship between the Growth Hormone/Insulin-like Growth Factor System and the Histological Features of Nonalcoholic Fatty Liver Disease.
Chishima S; Kogiso T; Matsushita N; Hashimoto E; Tokushige K
Intern Med; 2017; 56(5):473-480. PubMed ID: 28250290
[TBL] [Abstract][Full Text] [Related]
18. HOMA-IR: An independent predictor of advanced liver fibrosis in nondiabetic non-alcoholic fatty liver disease.
Fujii H; Imajo K; Yoneda M; Nakahara T; Hyogo H; Takahashi H; Hara T; Tanaka S; Sumida Y; Eguchi Y; Chayama K; Nakajima A; Nishimoto N; Kawada N;
J Gastroenterol Hepatol; 2019 Aug; 34(8):1390-1395. PubMed ID: 30600551
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction.
Adams LA; Feldstein A; Lindor KD; Angulo P
Hepatology; 2004 Apr; 39(4):909-14. PubMed ID: 15057893
[TBL] [Abstract][Full Text] [Related]
20. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
